Efficacy and Safety of Complete Intraureteral Stent Placement versus Conventional Stent Placement in Relieving Ureteral Stent Related Symptoms: A Randomized, Prospective, Single Blind, Multicenter Clinical Trial.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 5 3 2019
medline: 19 6 2019
entrez: 5 3 2019
Statut: ppublish

Résumé

We compared the efficacy and safety of complete and conventional stent placement to relieve ureteral stent related symptoms. We randomized 85 patients who required ureteral stent placement after lithotripsy into an intraureteral or a conventional stent placement group. The ureteral stent remained in place until postoperative day 14. We evaluated scores on the visual analog scale pain, the SF-36 (36-Item Short-Form Health Survey), the I-PSS (International Prostate Symptom Score) and the OABSS (Overactive Bladder Symptom Score) on postoperative days 3 and 14. We also assessed the total amount of analgesics administered and stent related complications. Overall the records of 80 patients were analyzed. Pain scores were significantly lower in the intraureteral vs the conventional stent placement group (postoperative days 3 and 14, 4.85 vs 9.78, p = 0.003, and 3.15 vs 6.20, p = 0.014, respectively). The total I-PSS score (postoperative days 3 and 14, 10.41 vs 14.90, p = 0.006, and 11.67 vs 16.10, p = 0.022, respectively) and total analgesic use (19.23 vs 88.54 mg, p <0.001) were significantly lower in the intraureteral group. However, differences in the SF-36 and the total OABSS scores did not significantly differ. On subgroup analysis the pain score in the groin and bladder areas, incomplete emptying and daytime frequency on the I-PSS, the quality of life index and daytime frequency on the OABSS were significantly better in the intraureteral stent placement group than the conventional stent placement group on postoperative days 3 and 14 (all p <0.05). There was no difference in the complication rate between the 2 groups. Intraureteral stent placement may be associated with less ureteral stent related discomfort than conventional stent placement. This novel placement method is feasible and safe, and it can be immediately used in daily clinical practice.

Identifiants

pubmed: 30829132
doi: 10.1097/JU.0000000000000196
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-170

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Takashi Yoshida (T)

Department of Urology and Andrology, Kori Hospital, Kansai Medical University , Osaka , Japan.
Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Takaaki Inoue (T)

Department of Urology and Andrology, General Medical Center, Kansai Medical University , Osaka , Japan.
Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Makoto Taguchi (M)

Department of Urology and Andrology, Kori Hospital, Kansai Medical University , Osaka , Japan.
Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Tomoaki Matsuzaki (T)

Department of Urology and Andrology, General Medical Center, Kansai Medical University , Osaka , Japan.
Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Takashi Murota (T)

Department of Urology and Andrology, General Medical Center, Kansai Medical University , Osaka , Japan.
Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Hidefumi Kinoshita (H)

Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Tadashi Matsuda (T)

Department of Urology and Andrology, Kansai Medical University , Osaka , Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH